The Canadian company highlights research which showed that the biggest challenge UK veterinary clinics face is the volume of pets (57%), followed by being overbooked (50%) and unable to take on new patients1.
In addition, earlier research has shown that 37%2 of vets are “actively” thinking about quitting, with 80%3 of the UK profession leaving to get a better work-life balance.
Hence the company offers a service through which UK practices can divert non-urgent calls to Vetster, to relieve some of the pressure.
Vetster says the most common cases treated by its veterinary surgeons are dermatology, gastrointestinal, respiratory, urinary tract, ophthalmology and musculoskeletal issues.
By diverting these cases to UK-licensed vets online, Vetster says it aims to relieve the pressure on clinics so that they can better serve pets in need of surgery, immunisations, bloodwork and other clinical treatments.
Mark Bordo, CEO and coFounder of Vetster said: “We are experiencing a global crisis in pet care exacerbated by the pandemic.
“Veterinarians are facing tremendous pressure to provide services to millions of pet owners.
"Vetster’s virtual care platform connects pet owners with licensed UK veterinarians to provide support when their clinic is closed, to answer a non-urgent question, and to improve the health outcomes of their pet and help ensure owners can care for their animals.”
Veterinary surgeons in search of a better work life balance can also join Vetster to create a virtual care practice that provides teletriage and addresses non-urgent issues.
Mark added: “Veterinarians are able to incorporate a new modality of practice to improve their work-life-balance, serve pet owners outside of a clinic environment, and hopefully practice for longer avoiding burnout and stress associated with this much-needed profession.”
Vetster is not available as a white label service at this time, and VetSurgeon.org understands that when it is clear an online consultation requires hands-on care, the owner is referred to the local practice on the platform, which may or may not be their normal practice.
Vets interested in offering consultations through Vetster can visit: https://vetster.com/en-gb/for-vets
Veterinary practices that are interested in having Vetster provide OOH support to clients, can visit: https://vetster.com/en-ca/for-vet-clinics
References
Formerly known as BSAVA’s Scottish Congress, Alba delegates will be treated to 28 lectures, four practicals, ten hours of CPD and a commercial exhibition.
There are three lecture streams: one for vets, another for vet nurses and another open to all.
Highlights include ‘Echocardiology’ with Kieran Borgeat, ‘Dermatology: What can nurses do?’ with Sue Paterson, and ‘Wildlife Triage’ with Jenna Richardson.
The practical sessions are open to all and include sampling techniques, suturing and a ferret clinical exam.
There's a gala dinner on Friday 16th from 7:30pm, starting with a drinks reception, followed by dinner and entertainment in the evening, with a live band and ceilidh dancing.
Angela McLaughlin, Scottish Regional Chair at the BSAVA said: “We are delighted that we are returning to Scotland after three years away as this is a great event that allows vets and nurses the opportunity to improve their skills and knowledge, while visiting an idyllic part of the country!”
For BSAVA members, tickets cost £240 +VAT for vets, £165 +VAT for veterinary nurses, and £65 +VAT for students.
Day tickets and non-member tickets are also available.
There's an additional fee of £10 +VAT for all practical sessions.
Tickets for the gala dinner are £35 for delegates and £55 for guests.
If you are looking for somewhere to stay, BSAVA’s hotel booking partner, BCD Meetings & Events, can help.
www.bsavaevents.com/bsavaalba2022
In particular, the two companies are focussing on the production of more video content, with Improve filming and sharing high quality clinical demonstrations, and VetSurgeon.org sharing peer-reviewed community-driven content and knowledge.
VetSurgeon.org Publishing Editor Arlo Guthrie said: “This partnership, which brings together the clinical knowledge and infrastructure of the UK’s leading veterinary training provider with the country’s longest-established online veterinary communities, will substantially increase the amount of valuable content we can bring our members.
“Together, we're going to make VetSurgeon.org THE community for authoritative information and opinions."
To ask questions or discuss the new partnership, click here.
The technology, developed by US firm SignalPET, sends X-rays through an AI machine algorithm to get a more or less instantaneous report, rather than needing a radiology specialist to analyse results, which can take up to three days.
IVC starting trialling the system with 22 of its practices last November and it quickly became clear that there were huge benefits, including saving time for clinicians, cost, and improving confidence in the diagnosis.
The majority of IVC's trial teams said they viewed the technology as a positive diagnostic aid, supporting their own professional opinion.
It also served as a learning tool, increasing the confidence and clinical independence of younger or newly qualified vets.
Sarah Merrell, Clinical Director at Lincvet, a group of IVC Evidensia practices in Lincoln and one of the trial clinics, said: “SignalPET has proved really valuable – giving us excellent support for radiography.
"It has been used by both our highly experienced and newly graduated clinicians to get a second set of ‘eyes’ on our cases giving reassurance and support when reading our radiographs.
“Overall, it has improved clinician confidence, reduced the pressure on senior vets, given us an additional tool for training and development, and greatly enhanced client understanding of our findings.”
Alistair Cliff, IVC Evidensia’s Deputy Chief Medical Officer, said: “The AI radiology process developed by SignalPET represents a real revolution in how results are analysed.
"The overwhelming success of our initial trial in November means we are confident in pushing ahead with rolling out the technology in the UK this year and eventually, in Europe too."
Jane (or John) Doe was charged with having stolen midazolam, butorphanol and promethazine hydrochloride from their practice for use other than for veterinary purposes, making false clinical records concerning the use of drugs on their own dogs to disguise the fact that the drugs were instead being used for non-veterinary uses, and drawing up medication taken from the practice into a syringe for the purpose of self-medicating.
In addition, they were charged that their conduct was dishonest.
The Committee found it proven that Jane/John Doe had taken approximately 150 vials of midazolam, 87 ampoules, 112 tablets and one elixir bottle of promethazine hydrocholoride, and 0.2mls of butorphanol together with Iml of midazolam for their dog at a time when their dog was, in fact, dead.
The Committee also found it proven that the defendant had drawn up medication for the purpose of self-medicating, and had created false clinical records.
In deciding the sanction, the Committee concluded that the respondent had abused their position of trust, that their actions were dishonest, prolonged and repeated in nature, and undermined the reputation of the profession as a whole.
Therefore the only appropriate action was removal from the Register.
Unusually, the RCVS did not issue a press release about this case, as it normally does.
There was also a protracted delay between the hearing and the report of the hearing being published on the College website.
Furthermore, when it was finally published, the report had been redacted to remove any reference to the name, gender or location of the respondent.
When asked why, the College said: "Matters of a highly confidential nature arose following the hearing which led to a delay in the decisions being published.
“The decisions have been redacted and we cannot provide the reasons for the redactions as that would necessarily involve disclosure of confidential and personal information.
"However, the circumstances are considered to be exceptional and the College’s decision to make the redactions was only made following very careful consideration of evidence provided to the RCVS.
"The decision has been published on the RCVS website in its redacted form and in view of the timeframe and the circumstances, it has not been considered appropriate to issue a press release.”
CommentThe College will for sure have had very good reasons for redacting the name of the respondent in this case.
One has to assume there must have been a very real threat to the respondent’s life, and under those circumstances, confidentiality is absolutely right and proper.
However, whatever the reason, secrecy is never a good look, especially when it comes in the form of a cape worn by a regulator.
So it is frustrating to hear that the College has again made a rod for its own back, when it could so easily have included a very general one-line explanation for why it felt redaction was necessary, without compromising the individual’s confidentiality.
It would have been enough, for example, just to say that the College felt there was a risk to life. People would accept that.
The BVA is also calling on Government to tighten pet import rules.
The advice follows news about a positive Brucella canis test in a rescue dog imported from Belarus in March this year.
The woman fostering the dog was hospitalised after coming into close contact with it, in the UK’s first confirmed dog-to-human transmission.
The foster animal and four pet dogs who were exposed to the disease, three of whom also tested positive, all had to be euthanised.
Data released by the Government shows a steep rise in confirmed Brucella canis cases since the start of 2020, rising from just three before that year to 107 till July this year.
The dogs were all either imported, had returned from holiday overseas, or been bred with an imported dog.
BVA is asking veterinary teams to:
British Veterinary Association President Justine Shotton said: “This recent case of Brucella canis in a foster dog is extremely tragic and highlights why vets have long raised concerns over the real and serious risks of importing ‘Trojan’ rescue dogs with unknown health histories into the UK.
“We know there is an added public health risk too, including for veterinary teams who treat and handle these animals, from contact with an infected dog’s contaminated body tissues and fluids.
"BVA continues to call on the Government to take urgent action to introduce stricter pet import measures, including mandatory pre-import testing, so we can minimise the spread of Brucella canis and other emerging diseases.
"We are also calling for the strengthening of enforcement provisions and checks on dogs brought into the country through the commercial route."
The 2021 B. canis risk view and statement by Public Health England (now UK Health Security Agency) contains vital information and recommendations for veterinary professionals: here:https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/960013/20210210_Brucella_canis_statement.pdf
BVA’s recommendations on tightening pet travel legislation: https://www.bva.co.uk/uploadedFiles/Content/News,_campaigns_and_policies/Policies/Companion_animals/BVA%20Position%20on%20Pet%20Travel%20Full.pdf
Danilon is used to relieve the pain caused by musculoskeletal conditions, such as osteoarthritis (OA), bursitis, laminitis, and soft tissue inflammation.
Some oral NSAIDs have been shown to increase the risk of gastric irritation¹ - a particular concern when treating of chronic conditions.
However, Animalcare points to a study² in which horses given Danilon Gold showed a reduced number of ulcers and those that did appear were less severe.
The area of gastric mucosa affected was also five times less.
Animalcare says accurate administration is critical for clinical success.
To support this, Danilon Gold is presented in a coloured granule formulation and is now available in both 3g and 10g sachets.
Q Fever is caused by the bacterium Coxiella burnetii, which can infect humans, cattle, goats, sheep and many other mammals, as well as reptiles, ticks and birds.
Known originally as Query fever, it was first identified in Australia in 1935 after an outbreak of disease in abattoir workers.
Ceva says half of UK dairy farms may be at risk of Q Fever1, 2.
The webinar, which will be presented by Jonathan Statham MA VetMB DCHP FRCVS (pictured right), an RCVS-registered specialist in cattle health and co-author of the ‘Dairy Herd Health’ textbook, will count towards 1.5 hours of CPD.
It will cover the UK prevalence of Q Fever in herds, its cause and transmission, together with identification and diagnostics.
It will also look at the variations between livestock species, disease prevention and its risk to humans as a zoonosis.
Jonathan said: "Q Fever is of much higher profile in many other parts of the world such as Australia and has been notifiable for some years with national testing programmes in a number of European countries such as Germany.
“Recently Q Fever has become notifiable in the UK and climate change is changing the future risk profile."
Renzo Di Florio, veterinary advisor at Ceva said: “The disease causes issues with reproduction and fertility and has the potential to have significant impact on livestock health and productivity.
"However, awareness is low amongst the farming industry.
“Our Q Fever webinar will help raise awareness of the disease and the preventative measures that can be put in place to help protect those working with livestock on a regular basis and reduce the impact of Q Fever on farms.
To register for the webinar or if you have further questions, e-mail cevauk-webinars@ceva.com
The buy-out was led by Professor Nick Bacon, Clinical Director, Dr Laurent Findji, Senior Clinician, Dr Jonathan Bray and Dr Gerard McLauchlan, who will collectively take the hospital forward with the financial backing of a small team of external investors.
Professor Noel Fitzpatrick will continue to lead Fitzpatrick Referrals Orthopaedics and Neurology and Fitzpatrick Referrals Institute for the Restoration of Skeletal Tissue which are both based in Eashing, Surrey.
Fitzpatrick Referrals Oncology and Soft Tissue is rebranding as AURA Veterinary, continuing to focus on animal oncology, soft tissue surgery, interventional radiology and internal medicine.
Under the new management team, AURA Veterinary says it has plans to invest in its team, equipment, scientific innovation and research.
Noel said: “I am proud of everything and everyone who has been part of the journey over the last seven years.
"It is a world-class hospital with an unrivalled team and the foundation we have built together is incredible.
"The time is now right for the team to embark on the next part of their journey - allowing me to also go forward and focus my passion, energy and time at Fitzpatrick Referrals Orthopaedics and Neurology and lead that team into its exciting new phase.”
Nick Bacon, Clinical Director, said: “It was a wonderful opportunity to be involved with a hospital like this from the very beginning, and it’s exciting to be part of its new chapter.
"Laurent and I are hugely grateful to Noel for his vision in creating the hospital, which is unparalleled in the level of care, skill and innovation our team can provide for our patients.
"We look forward to the growth and success of AURA Veterinary.”
Photo: Dr Gerard McLauchlan (standing, back left, in darker scrubs), Professor Nick Bacon, Clinical Director (sitting, front left), Dr Jonathan Bray, (sitting, right), Dr Laurent Findji, Senior Clinician (standing, far right)
The centre, which is one of the largest animal hospitals in the UK, offers 14 specialist-led services.
Hospital director Daniel Hogan said: “The new hospital will provide the region with one of the largest and best-equipped veterinary centres in not only the UK, but also throughout Europe, with an extensive range of expertise in a wide variety of disciplines all under one roof.
“There will be seven operating theatres, 16 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and there are plans for a future hydrotherapy suite.
“The facilities also include a cutting-edge imaging suite, comprehensive treatment facilities and a new linear accelerator to assist our illustrious oncology team.
"We also plan to launch our emergency and critical care service in the first half of 2023.”
Southfields says it also aims to lead the industry in terms of staff wellbeing and sustainability.
Daniel said: “The increased size of the hospital will enable us to provide a dedicated staff wellbeing area and offer a range of activities which will benefit our team in both body and mind.
“Along with exercise and relaxation classes such as yoga and boxercise, we will have an education centre which will be able to offer some really exciting qualifications and courses for the wider profession.
“We’ll also be striving to care for both our community by working with Investors in the Environment (iiE) to introduce a bold green initiative to substantially reduce our environmental impact and enhance our sustainability.
https://southfields.co.uk/veterinary-professionals/new-hospital
The idea is that by raising money through exercise, which is documented to improve mental health, you'll be helping to boost your own wellbeing as well as supporting the wellbeing of others.
To take part, you need to team up with colleagues, then decide on a challenge such as an overall distance or a total step count you want to hit.
Then create a fundraising page through Just Giving, so you can share the link and spread the word about your event.
If you share photos of your fundraising on social media, be sure to tag Vetlife.
You can buy running vests and t-shirts from Vetlife through it’s website (use code Vetlife40! for 40% discount).
Vetlife trustee Richard Killen said “It is well recognised how important physical activity is for wellbeing and what better way to promote within your workplace than participating in this event.
"Vetlife is a great charity with ever-increasing demands on its services and it is hoped that much needed funds can be raised through the VMOM campaign.
"Vetlife will be grateful for any contributions to its work.”
https://helpline.vetlife.org.uk/
Using practices developed for human healthcare measurement, NewMetrica developed VetMetrica, which the company says can measure how an animal “feels” about its circumstances from its individual perspective.
Jim Brick, Vice President Commercial Development and Lifecycle and Innovation at Zoetis said: "This novel approach supports a significant shift in veterinary care and animal welfare more generally towards the attainment of good or excellent quality of life in companion animals.
"The benefits of NewMetrica’s digital instruments have been validated through scientific publications and the FDA, and the EMA has confirmed the algorithms that produce the results.”
Jamie Brannan, President International Operations, Zoetis added: "We expect NewMetrica’s tools and algorithms to support earlier detection and treatment of diseases as we gain more insight into the quality of life of our pets and be an important element of future product development.
“NewMetrica’s instruments will give us scientifically validated results for alleviation of OA pain that veterinarians and pet owners will appreciate and value.”
https://www.newmetrica.com
The paper, ‘Mortality Related to General Anaesthesia and Sedation in Dogs under UK Primary Veterinary Care’, published in Veterinary Anaesthesia and Analgesia1, used data from more than 150,000 dogs attending first opinion veterinary practices around the UK.
The study examined the overall risk of death for each dog which had at least one sedation and/or anaesthesia procedure over a set period of time.
The study also looked at anaesthesia related to neutering (spaying and castration) in dogs because these procedures are so common in the UK and anaesthetic risk can be a significant worry for owners.
The findings showed that currently there are 14 deaths in 10,000 dogs within two weeks of sedation/anaesthesia procedures carried out for any reason, of which 10 deaths per 10,000 are within 48 hours of these procedures.
For neutering surgeries in dogs, the risk is even smaller, with one death in 10,000 neuter procedures related to sedation and/or anaesthesia.
No association was seen between the age of puppies at the time of neutering and risk of death.
Factors associated with increased risk of sedation and anaesthetic-related death in this study included:
Certain breeds, such as Cocker Spaniels, were found to be at lower risk compared with mixed breeds.
The team also investigated whether flat-faced ‘brachycephalic’ breeds were associated with higher risk.
Surprisingly, longer-nosed ‘dolichocephalic’ breeds showed four times the odds of sedative/anaesthetic-related death compared with medium-length nose dogs, whereas no additional risk was seen in flat-faced breeds.
The authors of the paper say that overall, these results should provide some reassurance for the veterinary and dog-owning communities regarding the safety of neutering for young puppies, as well as the relative safety of sedatives and anaesthetics for more complex procedures.
For older dogs, those with poorer health or undergoing planned complex surgeries, the results emphasise the value of careful planning to manage the anaesthetic risks.
Urgent procedures, regardless of complexity, were shown to carry greater risk and therefore should be approached with high vigilance and caution.
Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC and co-author of the paper, said:
“This new VetCompass study can help owners deal with these fears by understanding the real anaesthetic risk is not that high: 14 deaths in every 10,000 dogs. Decision-making based on the known can now replace fear of the unknown.”
Full paper: https://doi.org/10.1016/j.vaa.2022.03.006 / https://www.sciencedirect.com/science/article/pii/S1467298722001015
Reference
The pack contains:
For more information, contact your local Dechra equine sales manager.
Taking place on 26th November, the event will focus on putting the Cat Friendly Principles into action within the veterinary clinic, including how to work with cats in challenging situations, the role of appropriate handling techniques and the use of anxiolytics and sedation.
Speakers include Dr Sarah Heath (Veterinary Specialist in Behavioural Medicine), Dr Matt Gurney (Veterinary Specialist in Anaesthesia and Analgesia), Linda Ryan (Veterinary Technician Specialist in Oncology and Behaviour) and Kelly Eyre (RVN).
Head of ISFM Dr Nathalie Dowgray said: “This has been a really exciting programme to put together.
"Some cats can be challenging in the veterinary clinic even when the team has made every effort to be cat friendly. We wanted to recognise that and include in our panel discussion real-life scenarios to equip vets and nurses with the tools they need for when things don’t go according to plan.”
The Feline Fine London congress is open to all veterinary professionals, including nurses and receptionists.
https://icatcare.org/isfmcongress-2022-london
Strangvac has been in development for over 25 years and Dechra says it's the first and only intramuscular vaccine to help protect against strangles.
Strangvac contains recombinant proteins CCE, Eq85 and IdeE from Streptococcus equi and has DIVA (Differentiating Infected from Vaccinated Animals) capability.
The vaccine contains no live bacteria or bacterial DNA, so will not trigger positive culture or PCR tests.
In trials the new vaccine protected more than 94% of horses1.
Dechra says it reduces the clinical signs of strangles including a high temperature, coughing, inappetence, difficulty swallowing and changes in demeanour, while also reducing the number of lymph node abscesses.
Strangvac can be given to foals from five months of age and two injections should be given at a four-week interval.
Horses at high risk of Streptococcus equi infection, such as those in livery, should be revaccinated after two months.
Based on measured antibody titres, immunological memory was found in horses following repeated vaccination six months after primary vaccination.
Dr Andrew Waller, chief scientific officer at Intervacc AB, the company that developed the vaccine, said: “Strangvac is a ground-breaking new vaccine which, alongside good stable management and biosecurity procedures, can play a really important role in improving herd immunity and reducing the number of strangles cases in the equine population, thereby preventing major economic loss to the equestrian industry.”
https://www.dechra.co.uk/equine/vaccines
The Clinical Supervisor course is designed to help veterinary surgeons to guide their students in developing the professional behaviours and Day One Skills they need to join the Register.
The course is also designed to complement any existing training that a vet who is a Clinical Supervisor has received from the college or university for which they are supervising the SVN.
RCVS Director of Veterinary Nursing Julie Dugmore said: “This course will help you undertake your role as a coach and assessor, ensuring your student has achieved the RCVS requirements by the time they have completed the practical elements of their training.
“It comprises modules that include the role and functions of a Clinical Supervisor, the types of professional behaviours SVNs need to develop and understanding of the Day One Skills in which they need to become competent.
"In addition, it will enhance the training Clinical Supervisors will receive from the relevant educational institution by promoting understanding of the RCVS requirements.”
www.rcvs.org.uk/vndayonecompetences
Sparking the Clinical Mind – How Collaboration Delivers Excellence in Research, which is free to download, looks at the importance of collaboration in delivering high quality research projects
The report includes new studies covering the management of canine idiopathic epilepsy, the signs of stress in hyperthyroid cats, breathing, accelerometry and sleep disturbances in brachycephalic dogs, and retinal vascular health in senior and geriatric cats.
Professor Luisa De Risio, Clinical Research & Excellence Director at Linnaeus, said: “This report is the result of working in partnership, which is a theme that comes up repeatedly in the report.
"Delivering high-quality clinical research requires a sharing of knowledge, ideas and perspectives.
"From the development of your hypothesis to the outcome of your results – the input of others can corroborate, challenge and ultimately improve a research project.
“To deliver the best quality care for animals, we widely rely on evidence-based medicine.
"This report aims to highlight areas where we can do even more to improve the health and wellbeing of our patients.”
Dr Darren Logan, Head of Research at the Waltham Petcare Science Institute, said: “The quality and scale of research from the veterinary profession is constantly improving, but greater collaboration will help us go even further.
"By opening discussions around the trends, challenges and opportunities in clinical research, I hope this report will help to generate further conversations between us all.”
To download the report, visit: bit.ly/3Bd86yc
Animalcare says the wipes deliver tartar reduction with some mechanical action without the difficulties that some owners experience when using a toothbrush. The company says they can also help owners grow more comfortable with handling their pets’ mouths before they progress to full toothbrushing.
Animalcare Senior Brand Manager Eleanor Workman Wright said: “With periodontal disease so common in dogs and cats, supporting owners to help them start and maintain an oral health regime for their pet is essential.
“Toothbrushing is, of course, the Gold Standard but it must be done frequently to achieve a significant degree of efficacy.
"For many owners this is just not possible and, if they find it difficult, the risk is that they then give up and their pet’s oral health is neglected.
"One of the founding principles of the Plaqtiv+ range is to offer proven technology in multiple formats which can be used daily by owners as an alternative to toothbrushing, as part of a programme to build up to toothbrushing or within a multi-modal framework.
"Launching our new dental wipes is the latest step in achieving this goal.”
To support Plaqtiv+, Animalcare has published a website with content for both veterinary professionals and pet owners.
For veterinary professionals, there's advice about how to start discussions with clients about dental care and tools to help them recognise signs of dental pain.
The pet owner site offers information on the importance of dental health in pets and advice on establishing a dental care regime.
www.dental.pet
The event aims to deliver the latest knowledge on parrot nutrition and welfare and provide an opportunity to collaborate on education and potential next steps for research.
The full programme is as follows:
Sarah Hormozi, Head of Science & Education at PFMA said: “We are hoping to make it a worthwhile event, where parrot experts, welfare groups and parrot food industry can share their knowledge and experience.
"Through discussions we will come up with collective decisions and steps forward to improve the health and welfare of parrots that are kept in captivity, especially from a diet and nutrition perspective."
For ticket prices and to register: https://www.pfma.org.uk/pfma-parrot-symposium-2022
The package includes pre-built templates, dedicated support during implementation, comprehensive training and 6 months’ free access from go-live to the cloud-based platform.
The company says it is launching this service after seeing the number of start-up practices reaching almost pre-pandemic levels according to Companies House data.
Scott Goodsir-Smyth, General Manager for the UK and Ireland at Provet Cloud said: "A progressive practice management system is essential for the smooth running of a modern veterinary practice, however selection and implementation can be stressful, particularly for start-ups when there are so many other important decisions to make.
"We have streamlined our implementation process and incorporated a number of out-of-the-box templates, pre-built wholesaler price lists and laboratory panels to speed up configuration and take the strain off our customers.
"We also understand that cash-flow is a major concern during ramp-up, so we are delighted to be able to offer start-ups in our region 6 months’ free access to the system, whilst they open and establish their practice’.
Training and support is provided by the UK Provet Cloud team, made up of qualified vets, nurses and practice managers.
Danny McClelland, implementation lead at Provet Cloud UK and Ireland, said: "We made a conscious decision to employ people with clinical or hands-on experience in practice for our implementation, training and support roles."
https://www.provet.cloud/veterinary-start-up-software
Dr Dyson was removed from the Register after she was found to have fabricated a letter from a fictitious Home Office Inspector in support of a paper she had submitted to a journal, explaining why conducting her research had not required a Home Office Licence.
The original Committee made its decision on the basis that her conduct was knowingly dishonest, was likely to bring the profession into disrepute and undermine public confidence in it, and, furthermore, risked undermining the Government’s system designed to promote animal welfare and research ethics.
In considering Dr Dyson’s application for restoration, the Disciplinary Committee took into account a number of factors: her acceptance of the findings of the Committee at the original hearing; the seriousness of the original findings; public protection; risks to animal welfare if she were to be allowed to practise again; the length of time off the Register; her conduct since being removed; her efforts to keep up to date in terms of knowledge, skills and developments in practice; the impact of the sanction on her; and public support for her.
The Committee found that while Dr Dyson had demonstrated some insight into her misconduct, had expressed remorse and admitted dishonesty, it was undermined by her continuing denial that she had been knowingly dishonest in her conduct, having attributed her actions to being in a dissociative state at the time.
In terms of seriousness, the Committee considered that Dr Dyson’s misconduct was at the highest end of the spectrum, having involved being dishonest with multiple people on multiple occasions, and then inventing a fictitious Home Office Inspector to continue the deceit.
The Committee also considered that public confidence in the profession and the RCVS as the regulator would be undermined were Dr Dyson to be allowed to be restored to the Register without genuinely accepting full responsibility for her actions.
In her favour, the Committee considered that there was no risk to the health and welfare of animals and that she had provided ample evidence of her efforts to keep up to date in terms of knowledge, skills and developments in practice should she be allowed to practise again.
In addition, she had made some progress, for example she was able to show some insight by the steps she had taken to avoid finding herself in such a stressful environment in the future. The Committee also considered the many positive testimonials it received from professional colleagues and clients.
Ultimately, however, the Committee decided to refuse Dr Dyson’s application.
Judith Way, chairing the Committee and speaking on its behalf, said: “The Committee considered that public confidence in veterinary surgeons and the profession will not be maintained if a veterinary surgeon who has been found to have committed very serious acts of dishonesty refuses to genuinely accept that that is the case.
“Dr Dyson says that she accepts the original Disciplinary Committee’s finding that she acted dishonestly, but that acceptance carries little weight in light of what she said in her application and has said in her evidence to this Committee, because it involves a theoretical or objective concept of dishonesty which has no bearing upon her actual state of mind at the time of the actions in question.
“By not being truly accountable for her dishonest actions, Dr Dyson has thus far been unable to demonstrate anything other than limited insight into her disgraceful conduct.
“In such circumstances, the Committee considered there would be a real and continuing risk to the reputation of the profession and to public confidence in the profession if Dr Dyson were restored to the Register.
"Conduct of this kind is of a particularly egregious nature for a member of this profession and particularly so of one so eminent in her field and looked up to by so many.
"The Committee was of the view that if a veterinary surgeon, who has committed such serious offences and shown so little insight were nonetheless now allowed to practise, the public’s trust in the profession was liable to be seriously undermined.”
www.rcvs.org.uk/disciplinary
The online book invites veterinary surgeons to leave written messages of condolence, and pictures.
The book will be available until Monday 3rd October.
Dr Melissa Donald MRCVS, President of the RCVS who will be attending the Queen’s state funeral on behalf of the College, said: “I, along with my colleagues in the Officer Team and on RCVS and VN Councils, were greatly saddened to learn of the death of Her Majesty the Queen last week.
“As our Patron and benefactor since her accession to the throne 70 years ago, as a keen supporter of the veterinary professions who had many interactions with its members, and as an animal-lover, we were keen to give veterinary surgeons and veterinary nurses the opportunity to leave messages of condolence, anecdotes about meeting Her Majesty, and tributes for her many years of duty and service to this country.
“After it closes, we plan to save a digital copy of the online book in the RCVS historical archives for posterity.”
Any nurses who have not received the original email should contact communications@rcvs.org.uk.
He takes over the role from Huw Griffiths at the end of BEVA Congress 7th -10th September 2022. Roger Smith becomes President Elect.
Following graduation from The University of Bristol in 2001, David worked in farm animal and equine practice in Somerset before completing an internship at Liphook Equine Hospital.
A three-year Horserace Betting Levy Board residency at The University of Glasgow and Liphook Equine Hospital enabled him to train as a specialist in equine internal medicine and to gain a masters by research into equine asthma and an RCVS certificate in equine medicine.
David spent several years at Liphook Equine Hospital in Hampshire and had spells at The Royal Veterinary College, London and Charles Sturt University in Australia before moving to Rainbow Equine Hospital in Yorkshire where he led the internal medicine and laboratory services as a director and subsequently a clinical director following the hospital’s acquisition by the VetPartners group.
David returned to his Westcountry roots in 2020 and now combines work as an independent equine medicine and therapeutics consultant with running the family farm on the edge of Exmoor.
He is chair of BEVA’s health and medicines committee.
During his presidential year David is keen to continue build on his recent work around antimicrobial and anthelmintic resistance as well as expanding BEVA’s global outreach to support more equine vets and have a greater impact on equine welfare.
He said: “I’ve had a great time being part of the profession for the past 20 years and I am now in a position to give something back.
“Huw has driven much activity in the past year around recruitment and retention and I hope to be able to build on this and action results from the recent survey, under Huw’s continued supervision. I am also determined to maintain momentum around BEVA’s antimicrobial and anthelmintic resistance work as well as step up collaboration internationally on these and other projects to extend BEVA’s global outreach.
“Around 99% of the world’s horses are cared for by around 1% of the world’s vets so we are not going to change things overnight; however, BEVA has so much to offer and we should use our resources to support equine welfare, irrespective of where equine vets and their patients live and work.”
Suprelorin 4.7mg is a sustained release implant containing deslorelin (a GnRH super agonist) which has been EMA and VMD approved for use in male cats from 3 months of age.
The implant provides temporary infertility and suppression of urine odour and of sexual behaviours such as libido, vocalisation, urine marking, and aggressiveness in intact male cats.
The implant typically lasts for at least 12 months1.
Virbac says that in most cats, testosterone levels drop within 2 weeks after implantation, followed by reduced testicular volume and reduced size of penile spines from weeks 4-8 after implantation.
Sexual behaviours begin to decrease within a week after treatment, starting with reduced vocalisation, followed by reduction in libido, urine odour, urine marking, and aggressiveness from 4 weeks after implantation.
Induction of infertility is achieved from approximately 6 weeks.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "The ability to use Suprelorin in male cats provides an opportunity for practices to offer a choice when it comes to neutering, and to tailor their recommendations to meet the individual needs of both the cat and the client.
"Suprelorin provides an ideal solution for cats where the client wants the benefit of surgery without the permanent loss of fertility, where there is an anaesthetic risk in high value kittens or where there is benefit to allow enough time between neutering, vaccination and homing to minimise stress".
The implant is inserted subcutaneously, under the loose skin on the back between the lower neck and the lumbar area.
Virbac says implantation is a quick procedure and does not require anaesthesia or hospitalisation, which can be of particular benefit in practices facing pressures on surgical waiting lists.
Suprelorin 4.7mg has also received a licensed claim in pre-pubertal female dogs for the induction of temporary infertility to delay the first oestrus and heat signs, and to prevent pregnancy at a young age in intact and healthy sexually immature female dogs.
The implant should be administered between 12 and 16 weeks of age.
For more information, talk to your Virbac Territory Manager or the Virbac Technical Team on 01359 243243.